Nachrichten

Pharmabiz15 Std.
PCI asks institutions to submit appeal regarding statutory documents for AY25-26
The Pharmacy Council of India (PCI) has directed all pharmacy institutions which have applied for approval from the Central ...
Pharmabiz15 Std.
Telangana DCA seizes counterfeit versions of Rosuvas F 20 & Rosuvas F 10 from distributors in Hyderabad
Acting on intelligence, the officials of the Drugs Control Administration (DCA) in Telangana recently conducted raids across Inderbagh, Koti, and Hyderabad, and seized counterfeit versions of 'Rosuvas ...
Pharmabiz15 Std.
TN PTA to organise protest meeting on June 25 against OTC policy & e-pharmacy
The chairman of the Tamil Nadu Pharmaceutical Traders Association (TN PTA), Mannargudi Ramachandran has informed Pharmabiz that the traditional pharma traders (chemists and druggists) in southern ...
Pharmabiz15 Std.
DGTR reschedules hearing in DASDA anti-dumping investigation as domestic industry shares evidence of losses
The Directorate General of Trade Remedies (DGTR) has announced a revised schedule for the oral hearing in the ongoing anti-dumping investigation concerning the import of 4,4 Diamino Stilbene 2,2 ...
Pharmabiz21 Std.
India needs multi-pronged strategy to meet demand for blood & cord blood: Dr Mrinalini Chaturvedi
India needs multi-pronged strategy to meet demand for blood & cord blood: Dr Mrinalini Chaturvedi: Nandita Vijayasimha, Bengaluru Saturday, June 21, 2025, 08:00 Hrs [IST] India no ...
Pharmabiz12 Std.
KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old
KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old: El Segundo, California Saturday, June 21, 2025, 17: ...
Pharmabiz14 Std.
Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML
Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...
Pharmabiz15 Std.
CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System
CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System: Boston Saturday, June 21, 2025, 14:00 Hrs [IST] CereVasc I ...
Pharmabiz1 T.
IPA-Mysuru charts ground-level strategy for effective implementation of revised Schedule M
IPA-Mysuru charts ground-level strategy for effective implementation of revised Schedule M: Nandita Vijayasimha, Bengaluru Friday, June 20, 2025, 08:00 Hrs [IST] The pharmaceutica ...
Pharmabiz19 Std.
EMA committee recommends marketing approval for Bayer’s Nubeqa for patients with advanced prostate cancer
EMA committee recommends marketing approval for Bayer’s Nubeqa for patients with advanced prostate cancer: Berlin Saturday, June 21, 2025, 10:00 Hrs [IST] The Committee for Medi ...
Pharmabiz11 Std.
GRAIL announces positive top-line results from Galleri PATHFINDER 2 study
GRAIL announces positive top-line results from Galleri PATHFINDER 2 study: Menlo Park, California Saturday, June 21, 2025, 18:00 Hrs [IST] GRAIL, Inc, a healthcare company whose m ...
Pharmabiz16 Std.
Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent
Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent: Wayne, Pennsylvania Saturday, June 21, 2025, 13:00 Hrs [IST] Palvella Therapeutics Inc, a clinical-sta ...